Biomerieux【BIM】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

買値

売値

出来高

0.00 日の範囲 0.00

88.25 52 週間の範囲 122.50

時価総額

前日終値

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

119,220

発行済株式数

117,946,146

配当利回り

PER

32.42

1 株当たり利益 (EPS)

3.66

歳入

3.9B

純利益

432.2M

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

www.biomerieux.com

本社

Lyon, Rhone, Fra

設立

Biomerieux is listed in the Biological Pds,ex Diagnstics sector of the ユーロネクスト with ticker BIM. The last closing price for Biomerieux was -. Over the last year, Biomerieux shares have traded in a share price range of 88.25 € to 122.50 €.

Biomerieux currently has 117,946,146 shares in issue. Biomerieux has a price to earnings ratio (PE ratio) of 32.42.

Oxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics

Oxford Nanopore Technologies plc (LSE: ONT) (“Oxford Nanopore”), the company delivering a new generation of nanopore-based molecular sensing...

Baxter and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test to Predict Persistent Severe Acute Kidney Injury

Reinforces Baxter and bioMérieux’s shared commitment to enhancing acute kidney injury (AKI) management through informed clinical decision-making...

bioMérieux: Notice of Information Related to Preparatory Documents for the Ordinary & Extraordinary Shareholders’ Meeting...

Regulatory News: An Ordinary and Extraordinary Shareholders’ Meeting of bioMérieux (Paris:BIM) is called at 2:00 p.m. on May 20, 2021 at 376...

bioMérieux : Informations mensuelles relatives au nombre total de droits de vote et d’actions prévues par l’article L. ...

Regulatory News: bioMérieux (Paris:BIM) : Code : BIM - Code ISIN : FR0013280286 Date d’arrêt des informations Nombre d’actions Nombre total de...

bioMérieux annonce le marquage CE du test TB IGRA® (tuberculose) sur VIDAS®

Regulatory News: A l’occasion de la Journée mondiale de lutte contre la tuberculose, bioMérieux (Paris:BIM), acteur mondial dans le domaine du...

bioMérieux reçoit une autorisation De Novo de la FDA pour le panel Respiratoire BIOFIRE® 2.1 (RP2.1) incluant le SARS-CoV-2

Regulatory News: bioMérieux (Paris:BIM), acteur majeur dans le domaine du diagnostic in vitro, annonce que sa filiale spécialisée dans les tests...

bioMérieux : Communiqué de mise à disposition du Document d’enregistrement universel incluant le rapport financier annue...

Regulatory News: Le Document d’enregistrement universel incluant le rapport financier annuel au 31 décembre 2020 de bioMérieux (Paris:BIM) a été...

期間 †	始値	高値	安値	平均出来高	VWAP
1	122	122.5	118	105367	120.88374573	DE
4	119.7	122.5	114.8	116787	119.139608	DE
12	117.6	122.5	103	119220	116.73480412	DE
26	101.8	122.5	100.6	115007	114.52801295	DE
52	91.05	122.5	88.25	104809	108.05185746	DE
156	83.88	122.5	77.48	101582	99.97165725	DE
260	117.5	144.8	77.48	112855	104.21740097	DE

BIM - Frequently Asked Questions (FAQ)

What is the current Biomerieux share price?

The current share price of Biomerieux is 0.00 €

How many Biomerieux shares are in issue?

Biomerieux has 117,946,146 shares in issue

What is the 1 year trading range for Biomerieux share price?

Biomerieux has traded in the range of 88.25 € to 122.50 € during the past year

What is the PE ratio of Biomerieux?

The price to earnings ratio of Biomerieux is 32.42

What is the cash to sales ratio of Biomerieux?

The cash to sales ratio of Biomerieux is 3.6

What is the reporting currency for Biomerieux?

Biomerieux reports financial results in EUR

What is the latest annual turnover for Biomerieux?

The latest annual turnover of Biomerieux is EUR 3.9B

What is the latest annual profit for Biomerieux?

The latest annual profit of Biomerieux is EUR 432.2M

What is the registered address of Biomerieux?

The registered address for Biomerieux is CHEMIN DE L'ORME, MARCY L’ETOILE, LYON, RHONE, 69280

What is the Biomerieux website address?

The website address for Biomerieux is www.biomerieux.com

Which industry sector does Biomerieux operate in?

Biomerieux operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

銘柄コード	株価	出来高
MLCOTCoretech 5	0.159 € (59.00%)	438.66k
ALBDMBD Multi-Media	11.95 € (36.10%)	314.93k
ALMEXMexedia SPA	6.45 € (26.47%)	81.29k
CJDSCrossject	0.0201 € (26.42%)	2.17M
VACBSPierre & Vacances	0.0555 € (23.33%)	108.01k
ALCHIAlchimie	0.1005 € (-56.30%)	558.34k
ALHPIHopium SA	0.0002 € (-50.00%)	199.6M
FPGUnion Tech Info	0.18 € (-43.57%)	437.07k
NAIWNew Amsterdam Invest NV	0.0222 € (-36.57%)	21.1k
ORDDSOrdissimo	0.007 € (-27.08%)	4.73k
ALHPIHopium SA	0.0002 € (-50.00%)	199.6M
ALRPDRapid Nutrition	0.0096 € (6.67%)	83.27M
BCPBanco Comercial Portugues SA	0.6494 € (-3.36%)	58.02M
ALNEVNeovacs	0.0034 € (6.25%)	42.55M
ALSRSSirius Media	0.0026 € (-7.14%)	28.17M

銘柄コード

株価

出来高

ALHPIHopium SA

0.0002 €

(-50.00%)

199.6M

ALRPDRapid Nutrition

0.0096 €

(6.67%)

83.27M

BCPBanco Comercial Portugues SA

0.6494 €

(-3.36%)

58.02M

ALNEVNeovacs

0.0034 €

(6.25%)

42.55M

ALSRSSirius Media

0.0026 €

(-7.14%)

28.17M

サインイン

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Biomerieux (BIM)

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

Biomerieux について

BIM 最新ニュース

Oxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics

Baxter and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test to Predict Persistent Severe Acute Kidney Injury

bioMérieux: Notice of Information Related to Preparatory Documents for the Ordinary & Extraordinary Shareholders’ Meeting...

bioMérieux : Informations mensuelles relatives au nombre total de droits de vote et d’actions prévues par l’article L. ...

bioMérieux annonce le marquage CE du test TB IGRA® (tuberculose) sur VIDAS®

bioMérieux reçoit une autorisation De Novo de la FDA pour le panel Respiratoire BIOFIRE® 2.1 (RP2.1) incluant le SARS-CoV-2

bioMérieux : Communiqué de mise à disposition du Document d’enregistrement universel incluant le rapport financier annue...

BIM - Frequently Asked Questions (FAQ)

ムーバー

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Biomerieux (BIM) 銘柄情報

Biomerieux (BIM)

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

Biomerieux について

BIM 最新ニュース

Oxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement to Develop Innovative Infectious Disease Diagnostics

Baxter and bioMérieux Announce CE Mark for NEPHROCLEAR™ CCL14 Test to Predict Persistent Severe Acute Kidney Injury

bioMérieux: Notice of Information Related to Preparatory Documents for the Ordinary & Extraordinary Shareholders’ Meeting...

bioMérieux : Informations mensuelles relatives au nombre total de droits de vote et d’actions prévues par l’article L. ...

bioMérieux annonce le marquage CE du test TB IGRA® (tuberculose) sur VIDAS®

bioMérieux reçoit une autorisation De Novo de la FDA pour le panel Respiratoire BIOFIRE® 2.1 (RP2.1) incluant le SARS-CoV-2

bioMérieux : Communiqué de mise à disposition du Document d’enregistrement universel incluant le rapport financier annue...

BIM - Frequently Asked Questions (FAQ)

ムーバー

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

サインイン

広告を削除する